Kairos Pharma Ltd. (KAPA) Stock Price

0.5794 ▼ -0.0088 (-1.50%)
Open: 0.5703 Vol: 38.52K Day's range: 0.57 - 0.60 Mar 27, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
KAPA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.59▼ 0.59▼ 0.59▼ 0.60▼ 0.60▼
MA10 0.58▼ 0.58▼ 0.58▼ 0.60▼ 0.62▼
MA20 0.58▼ 0.58▼ 0.58▼ 0.61▼ 0.71▼
MA50 0.59▼ 0.60▼ 0.60▼ 0.64▼ 0.86▼
MA100 0.61▼ 0.62▼ 0.62▼ 0.73▼ N/A    
MA200 0.62▼ 0.63▼ 0.67▼ 0.90▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▼ 0.000▲ 0.001▲ 0.000▲ -0.006▼
RSI 42.629▼ 42.385▼ 42.484▼ 42.180▼ 40.340▼
STOCH 25.945     37.817     41.371     65.251     14.924▼
WILL %R -100.000▼ -88.419▼ -88.419▼ -62.290     -90.314▼
CCI -134.040▼ -90.830     -89.081     -105.673▼ -71.759    
Latest Filters Detected On KAPA
▼ GAP $KAPA Open Gap Down %3 Set Alert
▼ GAP $KAPA Open Gap Down %2 Set Alert
Kairos Pharma Ltd. News
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
Monday, March 02, 2026 03:30 AM
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces that it has entered into binding terms to acquire ...
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
Friday, February 27, 2026 01:21 PM
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces the signing of a term sheet for a strategic asset ...
Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer
Wednesday, December 17, 2025 12:15 AM
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced that it has been selected ...
KAPA historical stock data
date open high low close volume
27/03/26 0.5703 0.60 0.57 0.5794 38,521
26/03/26 0.5997 0.5997 0.57 0.5882 45,472
25/03/26 0.6168 0.6168 0.5861 0.6022 40,287
24/03/26 0.6066 0.6294 0.566 0.6294 86,249
23/03/26 0.59 0.6199 0.568 0.619 214,838
20/03/26 0.6027 0.62 0.554 0.5995 216,437
19/03/26 0.5922 0.62 0.5569 0.615 178,830
18/03/26 0.53 0.611 0.53 0.608 150,600
17/03/26 0.6202 0.6202 0.575 0.58 83,883
16/03/26 0.61 0.62 0.59 0.61 73,581
Quote Details
52wk Low:0.40
52wk High:2.11
Vol:38.52K
Avg Vol(3m):10.6M
1Y Chng:-42.63%
1M Chng:-3.11%
Add to Watch List
More Information
Index N/A
Market Cap. 12.20M